Please use this identifier to cite or link to this item: https://ninho.inca.gov.br/jspui/handle/123456789/14591
Full metadata record
DC FieldValueLanguage
dc.contributor.authorInstituto Nacional de Câncer José Alencar Gomes da Silva-
dc.contributor.authorInstituto Nacional de Câncer (Brasil)-
dc.contributor.authorINCA-
dc.date.accessioned2023-08-10T12:34:50Z-
dc.date.available2023-08-10T12:34:50Z-
dc.date.issued2021-06-
dc.identifier.citationINSTITUTO NACIONAL DE CÂNCER (Brasil). Entrevista: Marcelo Alves Soares, pesquisador do INCA e professor da UFRJ. Rede Câncer, Rio de Janeiro, v. 48, p. 21-23, jun. 2021.pt_BR
dc.identifier.urihttps://ninho.inca.gov.br/jspui/handle/123456789/14591-
dc.descriptionp. 21-23.: il. color.pt_BR
dc.language.isoporpt_BR
dc.publisherINCApt_BR
dc.subjectSoares, Marcelo Alvespt_BR
dc.subjectCoronaviruspt_BR
dc.subjectNeoplasiaspt_BR
dc.subjectNeoplasmspt_BR
dc.subjectVacinas contra COVID-19pt_BR
dc.subjectCOVID-19 Vaccinespt_BR
dc.subjectVacunas contra la COVID-19pt_BR
dc.titleEntrevista: Marcelo Alves Soares, pesquisador do INCA e professor da UFRJpt_BR
dc.title.alternativeRede Câncer 48pt_BR
dc.TypeArticlept_BR
Appears in Collections:Rede Câncer 48

Files in This Item:
File Description SizeFormat 
Entrevista.pdf401.13 kBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.